Mayke Oesterholt

1PUBLICATIONS
10CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Oct 23, 2024
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).

Nicholas Turner, Cristina Saura, Philippe Aftimos

Pageof 1

Frequent Collaborators

1 joint publications

Nicholas Turner

1 joint publications

Cristina Saura

1 joint publications

Philippe Aftimos

1 joint publications

Evelyn van den Tweel

1 joint publications

Marco Colleoni

1 joint publications

Kevin Punie

1 joint publications

Agostina Stradella

1 joint publications

Sylvain Ladoire

1 joint publications

Joline Si Jing Lim

1 joint publications

Tira J Tan

Frequent Collaborators

1 joint publications

Nicholas Turner

1 joint publications

Cristina Saura

1 joint publications

Philippe Aftimos

1 joint publications

Evelyn van den Tweel

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

1.9K
See more related videos

Top Related Videos

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on : Aug 18, 2023

1.9K
See more related videos